Major Growth Boosters:

Skin cancer diagnosis

Skin cancer diagnosis is one of the most important applications of dermatology diagnostic devices. Over the years, the prevalence of cancer has increased rapidly across the globe. According to a study by the National Cancer Institute, skin cancer represents 4.6% of all new cancer cases in the U.S., and it is estimated that there will be 76,100 new cases of melanoma of the skin in 2014. This is the largest and the fastest-growing application segment in the dermatology diagnostic devices market. The large share of this segment can be attributed to the rising incidence of skin disorders and increasing awareness regarding aesthetic procedures.

Hair removal and skin rejuvenation

Dermatologists use lasers and light-based sources to safely and effectively remove unwanted hair with low patient discomfort and minimal complications as compared to other methods. Laser devices make use of a strong, pulsating light to remove unwanted hair. Intense pulse light (IPL), diode laser, Nd:YAG laser, and ruby lasers are the most commonly used devices for hair removal procedures. According to the American Society for Aesthetic Plastic Surgery, Americans spent over USD 11 billion on various cosmetic procedures in 2012, of which, USD 367 million was spent on procedures such as laser hair removal.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=154

Skin rejuvenation helps diminish imperfections on the skin and reduces the effects of aging, sunburn, and other skin disorders. Nonablative laser rejuvenation, intense pulsed light (IPL), photodynamic therapy (PDT), fractional laser rejuvenation, and ablative laser resurfacing are some of the commonly used laser and light techniques for skin rejuvenation. Of these, the most popular medical devices for nonablative skin rejuvenation are visible light lasers, IPL, and radiofrequency devices.

Major Dermatology Devices Market Developments:

# In September 2016, Alma Lasers launched Alma LipoLife 3G, a liposuction solution offering maximum safety and proven clinical results. The platform offers a complete, all-in-one solution covering all stages of liposuction, skin tightening, and fat grafting.

# In August 2016, Michelson Diagnostics received U.S. FDA approval for its VivoSight Dx and Dynamic OCT products. VivoSight Dx is an Optical Coherence Tomography (OCT) system used for the real-time imaging of external tissues of the human body. The approval enables the company to sell these products in the American market.

# In November 2015, Lumenis completed the acquisition of Pollogen Ltd. (Israel). This acquisition strengthened Lumenis' portfolio of dermatology devices.

# In September 2014, Cynosure completed the acquisition of Ellman International, Inc. (U.S.). The transaction was completed for a sum of USD 13.2 million in cash.

# In December 2014, Cynosure entered into an agreement with El.En. S.p.A. (Italy). This agreement enables Cynosure to market and distribute MonaLisa Touch in the North America market. The MonaLisa Touch is a carbon dioxide (CO2) laser used for the treatment of vaginal atrophy.

Geographical Growth Scenario:

Based on region, the global dermatology devices market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the highest CAGR during the forecast period. Growth in this regional segment is driven by factors such as the rising incidence of skin diseases, increasing healthcare expenditure, and increasing awareness regarding aesthetic procedures.

Global Leaders:

Some of the major players operating in the dermatology devices market are Alma Lasers, Ltd. (Israel), Cutera, Inc. (U.S.), Cynosure, Inc. (U.S.), Lumenis, Ltd. (Israel), and Valeant Pharmaceuticals International, Inc. (Canada).

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=154

Target Audience for this Report:

# Dermatology Device Manufacturers
# Dermatology Device Distributors
# Healthcare Institutions (Hospitals, Medical Schools, Group Practices, Individual Surgeons, and Governing Bodies)
# Various Research and Consulting Companies
# Various Research Associations Related to Dermatology Devices

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]